Seung Hyun Kim

9PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biomechanical engineeringPredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 06, 2026
Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue Sarcoma.

Kum-Hee Yun, Nam Suk Sim, Su-Jin Shin

|Jan 10, 2026
New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming.

Young-Chang Park, Seung Hyun Kim

|Nov 13, 2025
Serum Phosphorus Is a Fast and Highly Sensitive Marker Predictive of a Complete Cure of Tumor-Induced Osteomalacia.

Seung Hyun Kim, Young Han Lee, NamKi Hong

|Feb 26, 2025
NELL2-PAX7 Transcriptional Cascade Suggests Activation Mechanism for RAD52-Dependent Alternative Lengthening of Telomeres During Malignant Transformation of Malignant Peripheral Nerve Sheath Tumors: Elongation of Telomeres and Poor Survival.

Jungwoo Lee, Eunji Choi, Hyoju Kim

|Feb 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study.

Jin-Hee Ahn, Jeeyun Lee, Changhee Park

|Jan 23, 2024
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.

Hee Jin Cho, Kum-Hee Yun, Su-Jin Shin

Pageof 2

Frequent Collaborators

3 joint publications

Hong In Yoon

3 joint publications

Sang Kyum Kim

3 joint publications

Kum-Hee Yun

3 joint publications

Wooyeol Baek